Zhi-Min Yu
Biographic Data
| ID | 7388288 |
|---|---|
| NAME | Zhi-Min Yu |
| GIVEN NAMES | Zhi-Min |
| FAMILY NAME | Yu |
| SIGNATURE | YU Z |
| AFFILIATIONS | Jiangxi Mental Health Center |
| ORCID | 0000-0002-8732-4811 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2019 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 0 |
Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
Cognitive deficits represent a core feature of schizophrenia. Previous studies have demonstrated that plasma asymmetric dimethylarginine (ADMA) was increased in patients with schizophrenia and correlated with cognitive impairments. Atypical antipsychotics can produce cognitive benefits in schizophrenia patients. In this study, we conducted a prospective observation trial to explore whether plasma ADMA may serve as an indicator for evaluating cogn…
No prominent works on this page.
Treatment Responses of Cognitive Function and Plasma Asymmetric Dimethylarginine to Atypical Antipsychotic in Patients With Schizophrenia
Cognitive deficits represent a core feature of schizophrenia. Previous studies have demonstrated that plasma asymmetric dimethylarginine (ADMA) was increased in patients with schizophrenia and correlated with cognitive impairments. Atypical antipsychotics can produce cognitive benefits in schizophrenia patients. In this study, we conducted a prospective observation trial to explore whether plasma ADMA may serve as an indicator for evaluating cogn…
Antipsychotic (1 work) · Asymmetric dimethylarginine (1 work) · Atypical antipsychotic (1 work) · Biology (1 work) · Bipolar Disorder and Treatment (1 work) · Clinical Psychology (1 work) · Clinical Psychology (1 work) · Cognition (1 work) · Genetics (1 work) · Internal Medicine (1 work)